kabutan

ROHTO PHARMA, 0.2％ Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 6 yen

Tue May 13, 2025 3:30 pm JST Earnings

4527 ROHTO PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

ROHTO PHARMACEUTICAL CO.,LTD. <4527> [TSE Prime] announced its financial results after the market closed on May 13th (15:30). The consolidated ordinary profit for the fiscal year ending March 2025 decreased 4.7% from the previous period to 40.4 billion yen. For the fiscal year ending March 2026, the consolidated ordinary profit is nearly flat with a slight increase of 0.2% to 40.5 billion yen. This will be the fifth consecutive term of revenue growth.

At the same time, the company has decided to increase the dividend this fiscal year to 42 yen, an increase of 6 yen from the previous fiscal year.

In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit increased 35.9% from the same period last year, reaching 7.04 billion yen. The operating profit margin improved from 6.9% in the same period last year to 8.1%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 238,664 33,959 35,568 26,377 115.6 22 May 12, 2023 J-GAAP
Mar, 2024 270,840 40,048 42,434 30,936 135.6 27 May 13, 2024 J-GAAP
Mar, 2025 308,625 38,939 40,430 31,006 136.1 36 May 13, 2025 J-GAAP
YoY +14.0% -2.8% -4.7% +0.2% +0.4%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 320,000 43,200 44,200 32,200 142.5 36 Feb 12, 2025 J-GAAP
Mar, 2025 Results 308,625 38,939 40,430 31,006 136.1 36 May 13, 2025 J-GAAP
Revision Rate -3.6% -9.9% -8.5% -3.7% -4.5%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 139,082 17,791 18,590 12,921 56.6 16 Nov 13, 2024 J-GAAP
Apr - Sep, 2025 Guidance ー ー ー ー － 21 May 13, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 270,840 40,048 42,434 30,936 135.6 27 May 13, 2024 J-GAAP
Mar, 2025 308,625 38,939 40,430 31,006 136.1 36 May 13, 2025 J-GAAP
Mar, 2026 Guidance 334,500 39,000 40,500 31,100 137.6 42 May 13, 2025 J-GAAP
YoY +8.4% +0.2% +0.2% +0.3% +1.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 69,677 4,786 5,187 4,779 21.0 6.9 May 13, 2024 J-GAAP
Apr - Jun, 2024 68,356 11,790 12,273 8,482 37.2 17.2 Aug 7, 2024 J-GAAP
Jul - Sep, 2024 70,726 6,001 6,317 4,439 19.5 8.5 Nov 13, 2024 J-GAAP
Oct - Dec, 2024 86,813 14,476 14,793 11,885 52.1 16.7 Feb 12, 2025 J-GAAP
Jan - Mar, 2025 82,730 6,672 7,047 6,200 27.2 8.1 May 13, 2025 J-GAAP
YoY +18.7% +39.4% +35.9% +29.7% +29.9%

Related Articles